FOCPX
Price
$20.29
Change
-$0.06 (-0.29%)
Updated
Sep 20 closing price
GFAFX
Price
$76.19
Change
-$0.14 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

FOCPX vs GFAFX

Header iconFOCPX vs GFAFX Comparison
Open Charts FOCPX vs GFAFXBanner chart's image
Fidelity OTC
Price$20.29
Change-$0.06 (-0.29%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer F1
Price$76.19
Change-$0.14 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FOCPX vs GFAFX Comparison Chart
Loading...
VS
FOCPX vs. GFAFX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FOCPX is a Buy and GFAFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
GFAFX has more cash in the bank: 290B vs. FOCPX (30.7B). GFAFX pays higher dividends than FOCPX: GFAFX (0.45) vs FOCPX (0.05). FOCPX was incepted earlier than GFAFX: FOCPX (40 years) vs GFAFX (24 years). GFAFX is a more actively managed with annual turnover of: 31.00 vs. FOCPX (15.00). FOCPX has a lower initial minimum investment than GFAFX: FOCPX (0) vs GFAFX (250). GFAFX annual gain was more profitable for investors over the last year : 23.62 vs. FOCPX (19.29). FOCPX return over 5 years is better than : 71.89 vs. GFAFX (50.55).
FOCPXGFAFXFOCPX / GFAFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence40 years24 years-
Gain YTD8.52919.27844%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets30.7B290B11%
Annual Yield % from dividends0.050.4511%
Returns for 1 year19.2923.6282%
Returns for 3 years1.08-3.34-32%
Returns for 5 years71.8950.55142%
Returns for 10 years148.2862.13239%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SSSS3.870.02
+0.52%
SuRo Capital Corp
KRT25.94-0.01
-0.04%
Karat Packaging
PR13.86-0.02
-0.14%
Permian Resources Corp
TNDM42.64-0.42
-0.98%
Tandem Diabetes Care
RSLS0.16-0.01
-3.16%
ReShape Lifesciences